Treatment of CNS disorders using Damino acid oxidase and D-aspartate oxidase antagonists

Details for Australian Patent Application No. 2002247939 (hide)

International Classifications

Event Publications

27 February 2003 Application Open to Public Inspection

Published as AU-B-2002247939

8 January 2004 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee from Genset to Genset S.A.

25 November 2004 Change of Name(s) of Applicant(s), Section 104

Genset S.A. The name of the applicant has been changed to Serono Genetics Institute S.A.

25 January 2007 Application Accepted

Published as AU-B-2002247939

31 May 2007 Standard Patent Sealed

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.